NGL Fine-Chem Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
May 15, 2023 at 08:57 am EDT
Share
NGL Fine-Chem Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 738.92 million compared to INR 840.64 million a year ago. Revenue was INR 759.92 million compared to INR 870.4 million a year ago. Net income was INR 93.25 million compared to INR 68.67 million a year ago. Basic earnings per share from continuing operations was INR 15.09 compared to INR 11.12 a year ago. Diluted earnings per share from continuing operations was INR 15.09 compared to INR 11.12 a year ago.
For the full year, sales was INR 2,780.81 million compared to INR 3,175.03 million a year ago. Revenue was INR 2,836.11 million compared to INR 3,281.86 million a year ago. Net income was INR 204.96 million compared to INR 498.97 million a year ago. Basic earnings per share from continuing operations was INR 33.18 compared to INR 80.77 a year ago. Diluted earnings per share from continuing operations was INR 33.18 compared to INR 80.77 a year ago.
NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.
NGL FINE-CHEM LIMITED 
